Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00989313 · ClinicalTrials.gov registry record
A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study
A clinical trial, sponsored by Peplin.
- Completed
- Registry status
- 43
- Enrollment target
NCT00989313 is a clinical trial that has completed, run by Peplin. The registered enrollment target is 43 participants.
The verdict
NCT00989313 has completed, sponsored by Peplin.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
This study is designed to follow up patients, who have participated in the PEP005-028 study and observed complete clearance of their Actinic Keratosis (AK) lesions, over a 12 month period to assess both recurrence of AK lesions and long term safety in the selected treatment area.
Interventions
- DRUG Lesion count
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2009-09 |
| Est. Completion | 2010-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00989313
The ClinicalTrials.gov registry entry for NCT00989313 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Peplin, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lesion count is the first listed.
NCT00989313 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00989313 about?
NCT00989313 is a clinical study titled "A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study". This study is designed to follow up patients, who have participated in the PEP005-028 study and observed complete clearance of their Actinic Keratosis (AK) lesions, over a 12 month period to assess both recurrence of AK lesions and long term safety in the selected treatment area.
What is the current status of trial NCT00989313?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2009-09. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00989313?
The interventions under investigation include: Lesion count (DRUG).
Who is sponsoring clinical trial NCT00989313?
This trial is sponsored by Peplin, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.